A Democratic senator has introduced a new bill that would create a federal regulatory framework for hemp-derived cannabinoids, allowing states to set their own rules for products such as CBD while also empowering the Food and Drug Administration (FDA) to ensure that certain safety standards are met in the marketplace—including making sure that products aren’t marketed to children.
The legislation from Sen. Ron Wyden (D-OR)—titled the Cannabinoid Safety and Regulation Act—comes at a pivotal time, with debates playing out at the state and congressional levels about how to address public health concerns related to the proliferation of largely unregulated intoxicating cannabinoid products since hemp and its derivatives were federally legalized under the 2018 Farm Bill.
Rather than impose an outright federal ban on hemp products containing traceable amounts of THC, as has been proposed in two major Republican-led pieces of legislation on the House side in recent months, Wyden’s bill offers a regulatory pathway that many hemp stakeholders view as a more sensible alternative that wouldn’t threaten to pull the rug out from under the industry.
“It’s unacceptable to slap fun cartoons and glitzy candy wrapper packaging on cannabis products meant for adults,” Wyden said. “That’s why I’m introducing the
Read full article on Marijuana Moment
